HIGHBRIDGE CAPITAL MANAGEMENT LLC - TRINITY BIOTECH INVT LTD ownership

TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 5 filers reported holding TRINITY BIOTECH INVT LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.7%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of TRINITY BIOTECH INVT LTD
ValueSharesWeighting
Q4 2021$37,754,0000.0%53,175,0000.0%0.82%
-17.4%
Q3 2021$37,754,0000.0%53,175,0000.0%1.00%
-4.7%
Q2 2021$37,754,0000.0%53,175,0000.0%1.05%
-30.4%
Q1 2021$37,754,0000.0%53,175,0000.0%1.50%
+4.1%
Q4 2020$37,754,000
+3.4%
53,175,000
+0.5%
1.45%
-26.5%
Q3 2020$36,518,000
+43.4%
52,925,000
+45.3%
1.97%
-9.1%
Q2 2020$25,457,000
+19.5%
36,425,000
+19.7%
2.17%
-5.0%
Q1 2020$21,298,000
-7.3%
30,425,0000.0%2.28%
-10.2%
Q4 2019$22,971,000
+26.4%
30,425,000
+15.1%
2.54%
-4.2%
Q3 2019$18,168,000
-11.3%
26,425,0000.0%2.65%
+95.7%
Q2 2019$20,480,000
-0.7%
26,425,0000.0%1.36%
+113.7%
Q1 2019$20,619,000
-1.2%
26,425,0000.0%0.63%
+2.9%
Q4 2018$20,876,000
-1.3%
26,425,0000.0%0.62%
+22.7%
Q3 2018$21,142,000
+69.2%
26,425,000
+71.3%
0.50%
+100.0%
Q2 2018$12,494,000
-25.9%
15,425,000
-24.5%
0.25%
-7.7%
Q1 2018$16,851,000
-0.4%
20,425,0000.0%0.27%
-9.9%
Q4 2017$16,912,000
-10.3%
20,425,000
-12.8%
0.30%
+7.1%
Q3 2017$18,863,000
-0.9%
23,425,0000.0%0.28%
-0.7%
Q2 2017$19,033,000
-0.3%
23,425,0000.0%0.28%
+2.5%
Q1 2017$19,091,000
-5.6%
23,425,000
-1.9%
0.28%
-23.1%
Q4 2016$20,234,000
-16.4%
23,875,000
-5.9%
0.36%
-6.0%
Q3 2016$24,217,000
+3.2%
25,375,0000.0%0.38%
+0.3%
Q2 2016$23,472,00025,375,0000.38%
Other shareholders
TRINITY BIOTECH INVT LTD shareholders Q4 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TRINITY BIOTECH INVT LTD shareholders